Authors:
Ch. Vinay Kumar Reddy,Dr. I. Rajasri,Dr. Sammaiah,A.Rajesh,DOI NO:
https://doi.org/10.26782/jmcms.2020.08.00001Keywords:
Corona Virus,COVID 19,Respiratory Syndrome,corona effects,Transmission of corona,effects of corona,Abstract
COVID-19, caused by a coronavirus, has led to a pandemic that threatens everyone. Everyone in the world is worrying about COVID-19 (Corona Virus Disease-19). In late December 2019 an unidentified Corona virus, currently named as COVID-19 emerged from Wuhan, China. In this paper a brief description is given on Corona virus, its effects, safety measures and various modes of transmission of virus. A comparative study also done on the situation and safety measures of various countries to control the pandemic. In our study, it is observed that this virus is not a living organism and it has a genetic material inside an envelope. It is covered with the fat envelope known as lipid envelope. There are two different types of viruses namely Endemic and Pandemic. Endemic is something belongs to a particular people or country where as Pandemic is an epidemic that spread’s over different countries and continents. An Epidemic is a disease which affects a large number of populations within the region. Many researchers are working on these viruses. Corona virus is an Epidemic initially as it was born in Wuhan, China but its geographical Spread turned it as Pandemic declared by World Health Organization (WHO)[XIII]. 200 plus countries effected with this Virus. Long ago the similar kind of RNA sequences was circulated in Bats also known as SARS- COV (1) which created severe acute respiratory problems to the victim. After few years another virus MERS- COV was identified[XVIII, XV].Refference:
I. Casanova, L. M., Jeon, S., Rutala, W. A., Weber, D. J., & Sobsey, M. D. (2010). Effects of Air Temperature and Relative Humidity on Coronavirus Survival on Surfaces. Applied and Environmental Microbiology, 76(9), 2712–2717.
II. Chang MH, Wu HH, Shih CI, et al. Association between influenza vaccination and reduced risks of major adverse cardiovascular events in elderly patients. Am Heart J 2017; 193:1–7.
III. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., … Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
IV. Cohen, J., & Kupferschmidt, K. (2020, March 20). Countries test tactics in ‘war’ against COVID-19. Retrieved April 1, 2020.
V. Di Pasquale G. Coronavirus COVID-19: quali implica- zioniperlacardiologia?GItalCardiol2020;21:243–245.
VI. Doremalen, N. V., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., … Munster, V. J. (2020). Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal of Medicine.
VII. Grady, D. (2020, February 6). China Begins Testing an Antiviral Drug in Coronavirus Patients. Retrieved February 11, 2020.
VIII. Griffiths, J. (2020, January 27). Wuhan coronavirus: Thousands of cases confirmed as China goes into emergency mode. Retrieved April 1, 2020.
IX. Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., … Zhong, N.-S. (2020). Clinical characteristics of 2019 novel coronavirus infection in China.
X. Holshue, M. L., Debolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., … Pillai, S. K. (2020). First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine.
XI. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
XII. Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., … Feng, Z. (2020). Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. New England Journal of Medicine.
XIII. Munster VJ, Koopmans M, van Doremalen N, et al. A novel coronavirus emerging in China — key questions for impact assessment. N Engl J Med 2020; 382(8):692–694.
XIV. Pittet D, Allegranzi B and Boyce J. The World Health Organization guidelines on hand hygiene in health care and their consensus recommendations. Infect Control Hosp Epidemiol 2009; 30:611–622.
XV. Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., … Qin, C. (2019). From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses, 11(1), 59.
XVI. Tapiwa, G., Cécile, K., Dongxuan, C., Andrea, T., Christel, F., Jacco, W., and Niel, H., Estimating the generation interval for COVID-19 based on symptom onset data.
XVII. Tindale, L., Coombe M., Stockdale, J., Garlock, E., Lau W., Saraswat M., … Colijn, C. (2020). Transmission interval estimates suggest pre-symptomatic spread of COVID-19.
XVIII. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus- infected pneumonia in Wuhan, China. JAMA 2020. Epub ahead of print, 7th February 2020. DOI: 10.1001/ jama.2020.1585.
XIX. Wang, M., Cao, R., Zhang, L. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res (2020).
XX. Wu, J. T., Leung, K., & Leung, G. M. (2020). Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.